H1 2017 Hypertension Pipeline Overview of Companies and Drug Profile Market Report
The Hypertension pipeline guide also reviews of key players involved in therapeutic development for Hypertension and features dormant and discontinued projects.
Complete report @ http://www.reportsnreports.com/reports/1057922-hypertension-pipeline-review-h1-2017.html
Key players are A1M Pharma AB, Actelion Ltd, Alnylam Pharmaceuticals Inc, Anacor Pharmaceuticals Inc, AnGes MG Inc, Arena Pharmaceuticals Inc, Ascendis Pharma A/S, Asklepion Pharmaceuticals LLC, AVEO Pharmaceuticals Inc, Bayer AG, Bial - Portela & Ca SA, Biolab Farmaceutica Ltda, BioRestorative Therapies Inc, Boryung Pharmaceutical Co Ltd, Bristol-Myers Squibb Company, Camurus AB, Capricor Therapeutics Inc, Celsion Corp, Celtaxsys Inc, Chiesi Farmaceutici SpA, Chong Kun Dang Pharmaceutical Corp, CJ HealthCare Corp, Conatus Pharmaceuticals Inc, Corion Biotech Srl, Cumberland Pharmaceuticals Inc, Cytokinetics Inc, Daewoong Co Ltd, Daewoong Pharmaceutical Co Ltd, Daiichi Sankyo Company Ltd, DiaMedica Therapeutics Inc, Eli Lilly and Company, Esperion Therapeutics Inc, F. Hoffmann-La Roche Ltd
The guide covers Hypertension therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I and Preclinical stages are 7, 1 and 2 respectively. Similarly, the Universities portfolio in Discovery stages comprises 1 molecules, respectively.
Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=1057922 .
Hypertension (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Purchase this research report Direct from http://www.reportsnreports.com/purchase.aspx?name=1057922
• The pipeline guide provides a snapshot of the global therapeutic landscape of Hypertension (Cardiovascular).
• The pipeline guide reviews pipeline therapeutics for Hypertension (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Hypertension (Cardiovascular) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Hypertension (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Hypertension (Cardiovascular)
List of Figures
Number of Products under Development for Hypertension, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Number of Products by Top 10 Targets, H1 2017
Number of Products by Stage and Top 10 Targets, H1 2017
Number of Products by Top 10 Mechanism of Actions, H1 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
Number of Products by Top 10 Routes of Administration, H1 2017
Number of Products by Stage and Top 10 Routes of Administration, H1 2017
Number of Products by Top 10 Molecule Types, H1 2017
Number of Products by Stage and Top 10 Molecule Types, H1 2017
ReportsnReports.com is single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help in purchase decision by mapping your information needs with our huge collection of reports.
2nd floor, metropole,
Next to inox theatre,
Bund garden road,
+ 1 888 391 5441
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release H1 2017 Hypertension Pipeline Overview of Companies and Drug Profile Market Report here
News-ID: 587932 • Views: 230
More Releases from Reports and Reports
World Diamond Jewelry Market Research Report 2015-2023
World Diamond Jewelry Market report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data. Global World Diamond Jewelry Market, provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The World Diamond Jewelry Market analysis is provided for the international Industry including development trends, competitive landscape analysis,
Global Gaucher Disease Treatment Industry Market Share Analysis Report 2017
Report on Global Gaucher Disease Treatment Industry Market With the valuation from the year 2017 to 2022 Based on the Gaucher Disease Treatment industrial chain, this report mainly elaborate the definition, types, applications and major players of Gaucher Disease Treatment market in details. Deep analysis about market status (2012-2017), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2017-2022), regional industrial layout characteristics and macroeconomic policies, industrial policy has
Global Electric Seats Market Research Report 2017
Reports on Global Electric Seats Market With the valuation from the year 2017 to 2022 Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Eye Wash Station in these regions, from 2012 to 2022 (forecast), The reports was drawn considering the following regions. North America Europe China Japan Southeast Asia India Global Elect GET A SAMPLE REPORT @ https://www.reportsmonitor.com/request-sample/?post=386158 Global Electric Seats Market research report as also taken into
Global IoT Microcontroller Market Expected to Grow at 16.06% CAGR to 2024
The leading players of the IoT Microcontroller market are Fujitsu, Atmel, Holtek, Infineon, Ixys Corporation, Renesas, Spansion, Texas Instruments, St Microelectronics, Microchip, Nuvoton, Nxp, Samsung. Complete report at http://www.reportsnreports.com/reports/1151616-global-internet-of-things-microcontroller-market-forecast-2017-2024.html The IoT Microcontroller Market estimated to expand from $1977 million in 2016 to $6490 million by 2024, at a CAGR of 16.06% during the forecast period. Expansion of internet of things market and increasing demand for automation across end-user industries are the primary
More Releases for Hypertension
4th International Conference on Hypertension & Healthcare
We take the privilege of hosting International Hypertension meetings worldwide and very excited to expand to 4th International Conference on Hypertension & Healthcare to be held in beautiful city Zurich, Switzerland in the month of September 10th- 11th, 2018. As with the three meetings, the Hypertension 2018 will be on high-level updates, debates, hot topics and future research directions in the areas of Cardiology, cardiovascular diseases, Pulmonary Hypertension, Hypertension &
Global Pulmonary Arterial Hypertension Market to 2024
Global Pulmonary Arterial Hypertension (PAH) market was valued at $5.0bn in 2015 and is forecast to grow at a modest 6.0% CAGR between 2015 and 2024, to result in 2024 global sales of $9.0bn. PAH is broadly split into two classes, primary or secondary. Primary pulmonary hypertension (PPH) refers to pulmonary hypertension occurring without an identifiable cause. Secondary pulmonary arterial hypertension (PAH) occurs in association with some other identifiable medical condition.
Hypertension: Often unnoticed, always a risk
Vital mushrooms provide a valuable contribution in the prevention and therapy of hypertension Hypertension is considered one of the greatest health problems of the modern age. In the United Kingdom alone, according to data from the NHS, about 12,5 million people - almost every fourth - are affected. The great danger: Although hypertension can cause further serious diseases, many sufferers do not suspect their hypertension. They feel well and have
H2 2017 Pulmonary Arterial Hypertension - Pipeline Review
"The Report Pulmonary Arterial Hypertension - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Arterial Hypertension - Pipeline Review, H2 2017, provides an overview of the Pulmonary Arterial Hypertension (Cardiovascular) pipeline landscape. Pulmonary arterial hypertension (PAH) is a type of high blood pressure that occurs in the
Ocular Hypertension - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Ocular Hypertension - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ocular Hypertension - Pipeline Review, H1 2017, provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous
Renal Hypertension: Diagnosis & Treatment
“Hypertension & Cardiovascular disease after Kidney Transplantation” is one of the workshops to be conducted by Dr. Hossein Tabriziani of Loma Linda University, USA under the session ‘Renal Hypertension’ at the meeting 2nd International Conference on Hypertension & Healthcare which is going to be held at Amsterdam, Netherlands during September 11-13, 2017. High blood pressure is a leading cause of kidney disease and kidney failure ESRD (end stage renal disease). Hypertension